| MR编号 | NL/H/1575/001 |
|---|
| 药品名称 | Ropivacaine Kabi 2 mg/ml solution for injection |
|---|
| 活性成分 | - ropivacaine hydrochloride 2.0 mg/ml
|
|---|
| 剂型 | Solution for injection |
|---|
| 上市许可持有人 | Fresenius Kabi Nederland B.V.
Amersfoortseweg 10 E
3712 BC Huis ter Heide, Utrecht
Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Ropivacain Kabi 2mg/ml Injektionslösung - Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- France (FR)
- Spain (ES)
- Portugal (PT)
Ropivacaína Kabi - Latvia (LV)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Cyprus (CY)
ROPIVACAINE KABI 2mg/ml SOLUTION FOR injection - Romania (RO)
Ropivacaina Kabi 2 mg/ml solutie injectabila - Malta (MT)
Ropivacaine Kabi 2 mg/ml - Poland (PL)
Ropivacaine Kabi - Austria (AT)
- Czechia (CZ)
Ropivacaine Kabi - Estonia (EE)
- Hungary (HU)
Ropivacaine Fresenius Kabi - Lithuania (LT)
|
|---|
| 许可日期 | 2010/03/29 |
|---|
| 最近更新日期 | 2024/08/10 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|